Aytu BioPharma, the Developer of Healight UVA Endotracheal Catheter, to Report Fourth Quarter and Fiscal 2022 Financial Results on Sept. 27, 2022
At AP News, Aytu BioPharma, Inc., a pharmaceutical company focused on commercializing novel therapeutics, with a development pipeline addressing rare, pediatric-onset disorders, will report financial…
More from InformationalMore posts in Informational »
- UV Business News – Hindustan Unilever Interested In Purchasing Pureit Water Purifier
- Houston, TX Health Care Construction Trends Include UV Systems For HVAC Installation
- Hydrogen Storage Solution Involves Chemical and Chaerge To Release Hydrogen Fuel From Hydrogen Boride Sheets Versus UV Irradiation
- Balancing Risks and Rewards: UV, IAQ, and Infection Control
- UV Sensitive Glue Capable of Holding A Clam Shell Chamber Closed Until Illuminated